Cargando…

Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling

PURPOSE: We developed an accessible method for labeling small extracellular vesicles (sEVs) without disrupting endogenous ligands. Using labeled sEVs administered to conscious rats, we developed a multiple compartment pharmacokinetic model to identify potential differences in the disposition of sEVs...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Thomas, Stratford, Robert E., Edwards, Madison E., Ferreira, Christina R., Benson, Eric A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602176/
https://www.ncbi.nlm.nih.gov/pubmed/34671921
http://dx.doi.org/10.1007/s11095-021-03102-z
_version_ 1784601522320965632
author De Luca, Thomas
Stratford, Robert E.
Edwards, Madison E.
Ferreira, Christina R.
Benson, Eric A.
author_facet De Luca, Thomas
Stratford, Robert E.
Edwards, Madison E.
Ferreira, Christina R.
Benson, Eric A.
author_sort De Luca, Thomas
collection PubMed
description PURPOSE: We developed an accessible method for labeling small extracellular vesicles (sEVs) without disrupting endogenous ligands. Using labeled sEVs administered to conscious rats, we developed a multiple compartment pharmacokinetic model to identify potential differences in the disposition of sEVs from three different cell types. METHODS: Crude sEVs were labeled with a non-homologous oligonucleotide and isolated from cell culture media using a commercial reagent. Jugular vein catheters were used to introduce EVs to conscious rats (n = 30) and to collect blood samples. Digital PCR was leveraged to allow for quantification over a wide dynamic range. Non-linear mixed effects analysis with first order conditional estimation – extended least squares (FOCE ELS) was used to estimate population-level parameters with associated intra-animal variability. RESULTS: 86.5% ± 1.5% (mean ± S.E.) of EV particles were in the 45–195 nm size range and demonstrated protein and lipid markers of endosomal origin. Incorporated oligonucleotide was stable in blood and detectable over five half-lives. Data were best described by a three-compartment model with one elimination from the central compartment. We performed an observation-based simulated posterior predictive evaluation with prediction-corrected visual predictive check. Covariate and bootstrap analyses identified cell type having an influence on peripheral volumes (V2 and V3) and clearance (Cl3). CONCLUSIONS: Our method relies upon established laboratory techniques, can be tailored to a variety of biological questions regarding the pharmacokinetic disposition of extracellular vesicles, and will provide a complementary approach for the of study EV ligand-receptor interactions in the context of EV uptake and targeted therapeutics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11095-021-03102-z.
format Online
Article
Text
id pubmed-8602176
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86021762021-12-03 Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling De Luca, Thomas Stratford, Robert E. Edwards, Madison E. Ferreira, Christina R. Benson, Eric A. Pharm Res Research Paper PURPOSE: We developed an accessible method for labeling small extracellular vesicles (sEVs) without disrupting endogenous ligands. Using labeled sEVs administered to conscious rats, we developed a multiple compartment pharmacokinetic model to identify potential differences in the disposition of sEVs from three different cell types. METHODS: Crude sEVs were labeled with a non-homologous oligonucleotide and isolated from cell culture media using a commercial reagent. Jugular vein catheters were used to introduce EVs to conscious rats (n = 30) and to collect blood samples. Digital PCR was leveraged to allow for quantification over a wide dynamic range. Non-linear mixed effects analysis with first order conditional estimation – extended least squares (FOCE ELS) was used to estimate population-level parameters with associated intra-animal variability. RESULTS: 86.5% ± 1.5% (mean ± S.E.) of EV particles were in the 45–195 nm size range and demonstrated protein and lipid markers of endosomal origin. Incorporated oligonucleotide was stable in blood and detectable over five half-lives. Data were best described by a three-compartment model with one elimination from the central compartment. We performed an observation-based simulated posterior predictive evaluation with prediction-corrected visual predictive check. Covariate and bootstrap analyses identified cell type having an influence on peripheral volumes (V2 and V3) and clearance (Cl3). CONCLUSIONS: Our method relies upon established laboratory techniques, can be tailored to a variety of biological questions regarding the pharmacokinetic disposition of extracellular vesicles, and will provide a complementary approach for the of study EV ligand-receptor interactions in the context of EV uptake and targeted therapeutics. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s11095-021-03102-z. Springer US 2021-10-20 2021 /pmc/articles/PMC8602176/ /pubmed/34671921 http://dx.doi.org/10.1007/s11095-021-03102-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Paper
De Luca, Thomas
Stratford, Robert E.
Edwards, Madison E.
Ferreira, Christina R.
Benson, Eric A.
Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling
title Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling
title_full Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling
title_fullStr Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling
title_full_unstemmed Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling
title_short Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling
title_sort novel quantification of extracellular vesicles with unaltered surface membranes using an internalized oligonucleotide tracer and applied pharmacokinetic multiple compartment modeling
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602176/
https://www.ncbi.nlm.nih.gov/pubmed/34671921
http://dx.doi.org/10.1007/s11095-021-03102-z
work_keys_str_mv AT delucathomas novelquantificationofextracellularvesicleswithunalteredsurfacemembranesusinganinternalizedoligonucleotidetracerandappliedpharmacokineticmultiplecompartmentmodeling
AT stratfordroberte novelquantificationofextracellularvesicleswithunalteredsurfacemembranesusinganinternalizedoligonucleotidetracerandappliedpharmacokineticmultiplecompartmentmodeling
AT edwardsmadisone novelquantificationofextracellularvesicleswithunalteredsurfacemembranesusinganinternalizedoligonucleotidetracerandappliedpharmacokineticmultiplecompartmentmodeling
AT ferreirachristinar novelquantificationofextracellularvesicleswithunalteredsurfacemembranesusinganinternalizedoligonucleotidetracerandappliedpharmacokineticmultiplecompartmentmodeling
AT bensonerica novelquantificationofextracellularvesicleswithunalteredsurfacemembranesusinganinternalizedoligonucleotidetracerandappliedpharmacokineticmultiplecompartmentmodeling